옵션 체인은 다양한 행사가격과 만기일에 대한 Lavoro의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Lavoro에 대한 시장 심리를 평가합니다..

Lavoro (NASDAQ:LVRO) 주식, 옵션 체인

Lavoro

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

ADSK

LVRO

SAIC

YGMZ

월요일 아침(현지 시간) 미국 주식 선물이 상승면서, 오늘 투자자의 관심을 끌 수 있는 일부 주식은 다음과 같다: Benzinga Pro의 데이터에 따르면 월스트리트는 사이언스 애플리케이션 인터내셔널(NYSE:SAIC)가 개장 전에 분기별 이익을 주당 1.92달러, 매출 18억 4천만 달러로 보고할 것으로 예상하고 있다. SAIC 주식은 시간외 거래에서 3.4% 상승한 139.20달러를 기록했다. 

사이언스 애플리케이션, 오토데스크 그리고 월요일 주목해야 할 주식 3종목

Lavoro Ltd

Clearmind Medicine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the publication of a patent by the Korean Intellectual Property Office (KIPO), South Korea's official patent and intellectual property authority. The patent covers the Company's innovative combination therapy of MEAI and N-Acylethanolamines for the treatment of cocaine addiction.
The patent is based on preclinical trial results led by Professor Gal Yadid and his team at the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University in Israel. These studies build upon earlier experiments in which animals treated with MEAI exhibited a significant reduction in cocaine-induced cravings.
Further research was conducted in rats to assess whether MEAI's effects on drug-seeking behavior extended to natural rewards, given that reward-based reinforcement is a fundamental survival mechanism across species. The study produced positive results, demonstrating that while MEAI reduced cocaine-seeking behavior, it did not impair the rats' response to natural rewards such as sucrose. This finding suggests that MEAI's impact on drug cravings is not tied to the general reward system but is specifically targeted at drug-related compulsions.
This pioneering research has led to multiple patent applications in the U.S. and other global jurisdictions and is part of Clearmind's ongoing collaboration with SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>) ("SciSparc"), a specialty clinical-stage pharmaceutical company focused on developing therapies for central nervous system disorders. The collaboration aims to combine Clearmind's MEAI, a novel proprietary psychedelic treatment for addiction and mental health, with SciSparc's PEA

Government

Regulations

CMND

SPRC

Clearmind Wins South Korea Patent for Psychedelic Therapy Targeting Cocaine Addiction

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10080426/Cango-0310-01.jpeg" alt="" class="wp-image-7456" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10080426/Cango-0310-01.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10080426/Cango-0310-01-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10080426/Cango-0310-01-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The company, whose main business was previously auto trading, said its revenue skyrocketed in the fourth quarter after its move into bitcoin mining
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul>
<li>Cango's revenue rose more than fivefold to 668 million yuan in last year's fourth quarter, following its launch of a bitcoin mining operation last November</li>
<li>The company will add 18 EH of new capacity by the end of this quarter, bringing its total to 50 EH, making it the world's second-largest bitcoin miner</li>
</ul>
There's nothing like a new business model to put some new spring into your step.
After watching its revenue dwindle for a year and a half,&nbsp;Cango Inc.&nbsp;(CANG.US) came roaring back in the final quarter of last year, following a major shift into the cryptocurrency mining business in November. This was no subtle shift either. The company's revenue skyrocketed by more than a factor of five to 668 million yuan ($92 million) for the quarter from 130.2 million yuan a year earlier.
The latest figure not only marked Cango's first year-on-year revenue growth since the second quarter of 2023, but was also its highest total since that quarter. And in one final impressive feat, the figure was light years ahead of the company's forecast just three months earlier for fourth-quarter revenue of just 15 million yuan to 17.5 million yuan – quite possibly the biggest revenue "beat" of all time for any company.
The crypto shift looks set to continue for Cango, which announced a major expansion to its mining capacity in the current quarter and the potential for more in the second half of the year. The company is also aware of the risks of tying its fate to such a volatile sector, and broadly discussed some of the steps it is taking to control such risk. As a newcomer to the industry, Cango is also still on a sharp learning curve, which is reflected in its relatively high costs for each bitcoin it mines compared with some older peers. Those higher costs also owe to Cango's asset-light business model that differs from many of its peers by requiring much lower up-front investment, but with higher operating costs.
The sudden revenue jolt owes completely to Cango's move into cryptocurrency in November. Before that, the company was engaged in the auto business, first as a car loan financier, and more recently as a provider of domestic and international car trading services. That was fine when China's car industry was booming for most of the 21st&nbsp;century, as it zipped past the U.S. to become the world's largest market.
But the market has become stuck in slow-growth mode over the last few years as China's economy slows, resulting in huge overcapacity built up over the boom years. That's led to endless price wars with most companies losing money, leading Cango to scale down its car business to avoid falling into the same trap.
Reaction to Cango's latest report after its release last Thursday was relatively muted, with its shares rising 2.1% the next day. The stock has doubled over the last six months since Cango first announced the move into crypto mining in early November. But notably, the shares are also down 28% so far this year, tracking an 8% drop for bitcoin, showing the company's future will inevitably follow bitcoin prices to some extent.
Reflecting its newness to the industry, Cango's shares currently trade at a relatively low forward price-to-earnings (P/E) ratio of between 4 and 8, based on our calculations using its likely profit for this year derived from its fourth-quarter performance. That's well behind the ratio of 40 for industry leader&nbsp;Mara&nbsp;(MARA.US). Better comparisons might be&nbsp;Cipher&nbsp;(CIFR.US) and&nbsp;Bitfufu&nbsp;(FUFU.US), which trade higher than Cango with P/E ratios of 12, implying Cango's stock could still have some upside as more investors discover the company.
<h4 class="wp-block-heading">High mining costs</h4>
Cango first announced its plans to purchase $400 million worth of mining machines in November, and completed the first tranche of that the same month with its acquisition of $250 million worth. The company currently operates more than 138,000 machines in the U.S., East Africa, Oman, Paraguay and Canada, with the U.S. hosting about 40% of its capacity.
That operation began mining in mid-November, minting 363.9 bitcoins that month and another 569.9 in December. It minted another 538.2 bitcoins in January and 472.2 in February. Over that period, its production fell from 18.4 bitcoins mined each day in December to 16.9 in February, reflecting the growing competition for new bitcoins that are created at a constant rate by an algorithm no matter how many people are engaged in mining.
The company's output should soon get a one-time boost, as Cango disclosed it expects to complete its acquisition of the remaining $150 million worth of mining machines by the end of this month. CEO Lin Jiayuan said Cango will focus on installing and operating that capacity in the first half of this year, and also improving its efficiency.
The company said its cost for mining each bitcoin, excluding depreciation of its mining machines, was $67,769.90 in the fourth quarter. While that's below the current industry average of about $86,000, according to the website MacroMicro, it's still quite a bit higher than Mara's $51,035 in its latest financial report. Cango noted that the new installations will raise its capacity from the current 32 exahashes (EH) to 50 EH, making it the world's second-biggest listed miner behind only Mara.
An important reason for its higher cost-per-bitcoin mined is Cango's capital-light business model, whereby it installs its machines at existing facilities built by others. By comparison, Mara and many others build their own mining facilities, requiring far more capital but significantly lowering electricity costs that are one of their biggest expenses. Cango also has lower depreciation costs through its use of second-hand mining machines, unlike others like Mara, which use new machines.
"In the second half (of 2025), we will pursue a hash rate expansion strategy, actively seeking valuable assets to increase our overall capacity," Lin said on Cango's investor call, suggesting that even more expansion could be coming.
In terms of operating costs, the rapid bitcoin business buildup was most evident in Cango's general and administrative expenses, which nearly tripled to 127.9 million yuan in the fourth quarter from 45.6 million yuan a year earlier. But the huge jump in revenue was more than enough to offset that, with the company reporting a 55.9 million yuan profit, reversing a 103.8 million yuan loss a year earlier.
Cango also commented on its older auto businesses, including its progress in winding down its original auto financing business. It also disclosed that its newest international business expected to make its first sales of about $15 million this year through the export 1,500 cars.
The company also discussed some of the steps it is taking to control risk related to price fluctuations, including its establishment of a "comprehensive market monitoring protocol and a robust policy analysis mechanism." On the regulatory front, one of the company's most immediate risks could be its base in China, where cryptocurrency is officially banned, even though all Cango's mining operations are outside the country. In that regard, it could ultimately follow many of its formerly Chinese peers by moving its headquarters overseas, with Singapore as one of the most popular destinations for such relocations.

Asia

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Cango's Fortunes Turn Around Following Move Into Bitcoin Mining

Citigroup analyst Jason Gursky initiates coverage on Karman Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRMN#NYSE">KRMN</a>) with a Buy rating and announces Price Target of $42.

Price Target

Initiation

Analyst Ratings

KRMN

Citigroup Initiates Coverage On Karman Holdings with Buy Rating, Announces Price Target of $42

Citigroup analyst Ariel Rosa upgrades Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from Sell to Neutral and announces $53 price target.

Upgrades

Citigroup Upgrades Knight-Swift to Neutral, Announces $53 Price Target

MLYS

Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times

Citigroup analyst Jeff Chung upgrades XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) from Neutral to Buy and raises the price target from $13.7 to $29.

XPEV

Citigroup Upgrades XPeng to Buy, Raises Price Target to $29

WIIM

Mineralys Therapeutics shares are trading higher after the company reported topline data from its pivotal LAUNCH-HTN Phase 3 and ADVANCE-HTN Phase 2 trials of Lorundrostat for hypertension. Both trials met the primary endpoint.

HC Wainwright &amp; Co. analyst Arthur He maintains Solid Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) with a Buy and raises the price target from $16 to $20.

SLDB

HC Wainwright & Co. Maintains Buy on Solid Biosciences, Raises Price Target to $20

Cheer Holding Reported FY24 Revenue Of $147.2M Vs $152.3M YoY, EPS Of $2.51 Vs $3.53 YoY

TRVI

Trevi Therapeutics shares are trading higher after the company reported topline results from its Phase 2a RIVER trial of Haduvio for RCC, which met the primary endpoint.

Citigroup analyst Keith Horowitz upgrades KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) from Neutral to Buy and announces $20 price target.

Citigroup Upgrades KeyCorp to Buy, Announces $20 Price Target

RDFN

Redfin shares are trading higher after Rocket Companies announced it will acquire the company in an all-stock transaction valued at $12.50 per share.

Rocket Companies shares are trading lower after the company announced it will acquire Redfin in an all-stock transaction valued at $12.50 per share.

Novo Nordisk shares are trading lower after the company reported Phase 3 results for CagriSema, showing 15.7% weight loss over 68 weeks.

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) with a Buy and maintains $6 price target.

Reiteration

ELEV

HC Wainwright & Co. Reiterates Buy on Elevation Oncology, Maintains $6 Price Target

DASH

DoorDash shares are trading higher amid the company joining the S&P 500.

Barclays analyst Julian Mitchell downgrades Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) from Equal-Weight to Underweight and lowers the price target from $135 to $110.

Downgrades

Barclays Downgrades Emerson Electric to Underweight, Lowers Price Target to $110

ABNB

Airbnb shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $165 to $185.

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Protagonist Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTGX#NASDAQ">PTGX</a>) with a Buy and maintains $54 price target.

PTGX

HC Wainwright & Co. Reiterates Buy on Protagonist Therapeutics, Maintains $54 Price Target

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.

GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

Press Releases

Lavoro to Participate in the 2024 World Agri-Tech Innovation Summit in San Francisco

Lavoro to Participate in the BMO Global Farm to Market Conference on May 15-16, 2024

Lavoro to Announce Fiscal Third Quarter 2024 Results on June 3rd, 2024

Lavoro Reports Fiscal Third Quarter 2024 Earnings Results¹

Financing

Lavoro Announces New R$310 Million 3-Year FIDC-Fiagro Credit Facility

Lavoro Sets Fiscal Fourth Quarter 2024 Earnings Conference Call for November 1st, 2024

Lavoro Reports Fiscal Fourth Quarter 2024 Earnings Results¹

Lavoro Sets Fiscal First Quarter 2025 Earnings Conference Call on February 3rd, 2025

Lavoro Reports Fiscal First Quarter 2025 Earnings Results

LVROW

Alta Equipment Group Inc. Class A Common Stock

Alta Equipment Group

BioNexus Gene Lab

BlueLinx Hldgs

Euro Tech Holdings Company Limited - Ordinary Shares

Euro Tech Hldgs

Custom Truck One Source, Inc. Common Stock

Custom Truck One Source

Dnow

Distribution Solutions Group, Inc. - Common Stock

Distribution Solns Gr

DXP Enterprises

EVI Industries

FGI Industries

Global Industrial

Hudson Technologies

iPower

Karat Packaging

MRC Global

Multi Ways Holdings Limited Ordinary Shares

Multi Ways Holdings

Simpple

Titan Machinery

Transcat

Willis Lease Finance Corporation - Common Stock

Willis Lease Finance

Xometry

ZKH Group Limited American Depositary Shares, each representing thirty-five (35) Class A Ordinary Shares

Comments

Lavoro

Lavoro (LVRO) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌